This important invention is one of several innovative technological advances incorporated in the new DuraMAX side firing fiber developed by Trimedyne. This new fiber will be marketed by Boston Scientific in the US and Japan and by Lumenis of Yokneam, Israel, a manufacturer of medical lasers, throughout the rest of the world.
Marketing of the new fiber by Boston Scientific and Lumenis is expected to commence when Boston Scientific completes its audit of Trimedyne’s manufacturing facility and quality system.
Trimedyne will also market a side firing laser fiber employing the new technology under its VaporMAX trademark for use with its Holmium Lasers to treat benign prostatic hyperplasia.